Cargando…
A systematic review of pharmacologic treatment efficacy for depression in older patients with cancer
BACKGROUND: Older adults ≥65 years of age represent the majority of new cancer diagnoses and are vulnerable to developing depression-like symptoms. Evaluation and management of depression in older cancer patients is underappreciated despite its high prevalence and impact on health-related quality of...
Autores principales: | Rabin, Erik E., Kim, Miri, Mozny, Andreas, Cardoza, Krislyn, Bell, April C., Zhai, Lijie, Bommi, Prashant, Lauing, Kristen L., King, Amanda L., Armstrong, Terri S., Walunas, Theresa L., Fang, Deyu, Roy, Ishan, Peipert, John D., Sieg, Erica, Mi, Xinlei, Amidei, Christina, Lukas, Rimas V., Wainwright, Derek A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968450/ https://www.ncbi.nlm.nih.gov/pubmed/35368609 http://dx.doi.org/10.1016/j.bbih.2022.100449 |
Ejemplares similares
-
Advanced Age in Humans and Mouse Models of Glioblastoma Show Decreased Survival from Extratumoral Influence
por: Johnson, Margaret, et al.
Publicado: (2023) -
A retrospective survival analysis of Glioblastoma patients treated with selective serotonin reuptake inhibitors
por: Otto-Meyer, Sebastian, et al.
Publicado: (2019) -
Identification
and Characterization of a Novel Indoleamine
2,3-Dioxygenase 1 Protein Degrader for Glioblastoma
por: Bollu, Lakshmi R., et al.
Publicado: (2022) -
Tumor Cell IDO Enhances Immune Suppression and Decreases Survival Independent of Tryptophan Metabolism in Glioblastoma
por: Zhai, Lijie, et al.
Publicado: (2021) -
Glioblastoma as an age-related neurological disorder in adults
por: Kim, Miri, et al.
Publicado: (2021)